S7E10: A new drug for acromegaly: an insider's look at the clinical trial

<p>With the newly announced launch of the phase 3 trial on Paltusotine, Crinetics new nonpeptide oral drug candidate for acromegaly, we asked Dr. Alessandra Casagrande, their new Medical Science Director, to give us her perspectives on this study.</p>